RBR‐5bw2wt.

Methods	Study design: RCT Duration: 52 weeks Location: Brazil
Participants	Population: 75 people with COPD Baseline characteristics: NR Inclusion criteria: inpatients with AECOPD Exclusion criteria: cognitive impairment, psychiatric illness, metastatic disease, severe heart disease
Interventions	Treatment arms Pharmacist‐led care programme (modified Dader method for hospitalised people with COPD) after discharge from hospital + usual care Usual care (pneumology or internal medicine services without pharmacist involvement)
Outcomes	Primary outcome: rate of hospitalisation due to AECOPD Secondary outcomes: quality of life, knowledge and techniques for inhaled medication, drug‐related issue rates
Notes	Funding: Hospital de Clínicas de Porto Alegre – UFRGS, Universidade Federal do Rio Grande do Sul